Exploration of tumor growth regression of quinoa and chia oil nanocapsules via the control of PIK3CA and MYC expression, anti-inflammation and cell proliferation inhibition, and their hepatorenal safety in rat breast cancer model

Bulletin of the National Research Centre

Table 3 GC/MS analysis of the unsaponifiable fraction of chia oil

No.	R_t	Compounds	M⁺	BP	Molecular formula	Relative %
1	9.35	2-Ethyl -1-Hexanol	130	57	C₈H₁₈O	12.72
2	12.57	Camphor	152	95	C₁₀ H₁₆ O	0.52
3	12.75	1-Dodecene	168	55	C₁₂H₂₄	0.45
4	13.02	β-Panasinsen	204	161	C₁₅H₂₄	0.27
5	13.29	1,2,4-Butanetriol	106	75	C₄H₁₀O₃	0.97
6	14.08	3,3-Diethoxy-1, 2-propanediol	164	103	C₇H₁₆O₄	22.81
7	17.48	Pentadecane	212	57	C₁₅H₃₂	0.31
8	19.05	1,1,3,3-Tetraethoxypropane	220	103	C₁₁H₂₄O₄	25.17
9	21.30	2,6-di-(tbutyl) 4-hydroxy4methyl-2,5-cyclohexadien-1-one	236	165/137	C₁₅H₂₄O₂	0.38
10	22.25	Butylated hydroxytoluene	220	205	C₁₅H₂₄O	8.76
11	26.50	Hexadecane	226	57	C₁₆H₃₄	0.29
12	29.38	6,10,14-trimethyl -2-Pentadecanone,	268	58	C₁₈H₃₆O	0.38
13	33.34	Spiro[androst-5 ene17,1′cyclobutan] 2′one,3-hydroxy,(3á,17á)	328	55	C₂₂H₃₂O₂	0.41
14	34.62	Phytol	296	71	C₂₀H₄₀O	0.31
15	52.98	Stigmast-5en-3-ol	414	55	C₂₉H₅₀O	0.48
		Total identified compounds				74.23%
		Non-identified				25.77%